Cargando…
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
INTRODUCTION: To evaluate the effects of the global coronavirus disease 2019 (COVID-19) pandemic on lung cancer trials, we surveyed investigators and collected aggregate enrollment data for lung cancer trials across the world before and during the pandemic. METHODS: A Data Collection Survey collecte...
Autores principales: | Smeltzer, Matthew P., Scagliotti, Giorgio V., Wakelee, Heather A., Mitsudomi, Tetsuya, Roy, Upal Basu, Clark, Russell C., Arndt, Renee, Pruett, Clayton D., Kelly, Karen L., Ujhazy, Peter, Johnson, Melissa L., Eralp, Yesim, Barrios, Carlos H., Barlesi, Fabrice, Hirsch, Fred R., Bunn, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851565/ https://www.ncbi.nlm.nih.gov/pubmed/35183774 http://dx.doi.org/10.1016/j.jtho.2022.01.017 |
Ejemplares similares
-
PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
por: Smeltzer, M., et al.
Publicado: (2021) -
Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer
por: Basu Roy, Upal, et al.
Publicado: (2021) -
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
por: Suda, Kenichi, et al.
Publicado: (2013) -
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021) -
Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)